Shadle P J, Ginsberg M H, Plow E F, Barondes S H
J Cell Biol. 1984 Dec;99(6):2056-60. doi: 10.1083/jcb.99.6.2056.
To identify platelet surface structures involved in adhesion to collagen, the effect of 16 murine antiplatelet membrane hybridoma antibodies were tested in a defined, in vitro assay. Four of these antibodies inhibited platelet-collagen adhesion and reacted with a polypeptide with Mr approximately 125,000, as determined by immunoblots after gel electrophoresis under reducing conditions. Through detailed studies with one of these antibodies, the monoclonal antibody PMI-1, the relevant antigen was identified as platelet glycoprotein IIb alpha, based upon (a) co-migration with this glycoprotein in two-dimensional gel electrophoresis and (b) co-purification by immunoaffinity chromatography with a protein with apparent Mr identical to that of glycoprotein III, under conditions in which glycoproteins IIb and III form a complex. Univalent antibody fragments prepared from monoclonal antibody PMI-1 inhibited greater than 80% of platelet-collagen adhesion, and inhibition was completely blocked by the immunopurified antigen. These results indicate that glycoprotein IIb participates in some aspect of platelet-collagen adhesion. In contrast, the purified antigen only partially neutralized a polyclonal antiserum that blocked platelet-collagen adhesion, to a maximum of approximately 25%, at saturating antigen concentrations. Thus, by these immunological criteria, glycoprotein IIb is not the only molecule involved in this process.
为了鉴定参与血小板与胶原蛋白黏附的血小板表面结构,在一种特定的体外试验中检测了16种鼠抗血小板膜杂交瘤抗体的作用。其中4种抗体抑制血小板与胶原蛋白的黏附,并与一种分子量约为125,000的多肽发生反应,这是在还原条件下进行凝胶电泳后通过免疫印迹法确定的。通过对其中一种抗体(单克隆抗体PMI-1)进行详细研究,基于以下两点将相关抗原鉴定为血小板糖蛋白IIbα:(a)在二维凝胶电泳中与该糖蛋白共同迁移;(b)在糖蛋白IIb和III形成复合物的条件下,通过免疫亲和层析与一种表观分子量与糖蛋白III相同的蛋白质共同纯化。从单克隆抗体PMI-1制备的单价抗体片段抑制了超过80%的血小板与胶原蛋白的黏附,并且这种抑制作用被免疫纯化的抗原完全阻断。这些结果表明糖蛋白IIb参与了血小板与胶原蛋白黏附的某些方面。相比之下,纯化的抗原仅部分中和了一种能阻断血小板与胶原蛋白黏附的多克隆抗血清,在饱和抗原浓度下,最大中和率约为25%。因此,根据这些免疫学标准,糖蛋白IIb不是参与这一过程的唯一分子。